Develops molecular diagnostic tests for clinical healthcare and life sciences research.
Dec 2025Revenue $2.09B/yrExpenses $1.62B/yr
No trend
Figures by year
Is Qiagen profitable?
Yes. In the 12 months to Dec 2025, revenue was $2.09B and expenses $1.62B.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $2.09B | $1.62B | $466M |
| Dec 2024 | $1.98B | $1.88B | $97.7M |
| Dec 2023 | $1.97B | $1.56B | $410M |
| Dec 2022 | $2.14B | $1.61B | $531M |
| Dec 2021 | $2.25B | $1.62B | $630M |
| Dec 2020 | $1.87B | $1.48B | $386M |
| Dec 2019 | $1.53B | $1.55B | −$26.1M |
| Dec 2018 | $1.50B | $1.24B | $267M |
| Dec 2017 | $1.42B | $1.26B | $153M |
| Dec 2016 | $1.34B | $1.24B | $98.8M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.